Alabama HB364 mandates health care professionals to discuss opioid risks before prescribing Schedule II controlled substances.

Alabama HB364 requires health care professionals to discuss opioid use risks with patients before issuing initial and third prescriptions for Schedule II controlled substances or opioid pain relief drugs. This includes discussing addiction risks, alternative treatments, and the dangers of mixing opioids with alcohol or other depressants. Exceptions apply for patients in active cancer treatment, receiving hospice care, or in long-term care facilities. The professional must document the discussion in the patient's medical records.

Alabama HB364 mandates health care professionals to discuss opioid risks before prescribing Schedule II controlled substances.

Alabama HB364 requires health care professionals to discuss opioid use risks with patients before issuing initial and third prescriptions for Schedule II controlled substances or opioid pain relief drugs. This includes discussing addiction risks, alternative treatments, and the dangers of mixing opioids with alcohol or other depressants. Exceptions apply for patients in active cancer treatment, receiving hospice care, or in long-term care facilities. The professional must document the discussion in the patient's medical records.